102 results
Page 3 of 6
8-K
EX-99.1
nyvjy0t
30 Apr 20
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations andCOVID-19 Response
7:19am
DEFA14A
7jwgr0xdweu24 rq
16 Apr 20
Additional proxy soliciting materials
4:04pm
8-K
EX-1.1
ejch5fd3a08
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
8-K
EX-99.1
hsi6c4o4y
2 May 19
Other Events
3:24pm
DEFA14A
cuuki8sunef
18 Apr 19
Additional proxy soliciting materials
4:07pm
8-K
EX-3.1
0ktca4cm8iml2ci70
19 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-99.1
6tbxiwoivthn3na
20 Jul 18
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients
11:21am
8-K
EX-99.2
64y31tku8 op0q4w1uqw
4 May 18
Results of Operations and Financial Condition
7:07am